Scv Bbi (Kcp Nominees) Limited investment portfolio

Bitrobius Genetics develops the Gentrafix™ platform, a plasmid‑based technology that delivers therapeutic DNA to every affected cell through intercellular transmission, aiming to treat genetic diseases, including those caused by mitochondrial gene mutations. The company targets the gene‑therapy market for diseases that currently have no effective treatments.

DELTA G LIMITED is a UK-based quantum sensing company that develops quantum gravity sensors and gravity sensing hardware. Their primary product is a quantum gravity gradiometer, an underground imaging system that uses quantum technology to measure gravity gradients for accurate mapping and navigation. The company targets sectors such as infrastructure, transportation, energy, and defense, providing spatial intelligence for subsurface imaging, navigation, and environmental monitoring in various environments, including those where GPS is unavailable.